Note: Ingredients listed on restricted chemical lists
EC/CAS
7631-86-9
Name of the chemical
Silver adsorbed on silicon dioxide
Concentration
>=1-<5
General Information
Version
2.0
Revision date
2023-08-17
Product name
Mobic tablets 7.5 mg, 15 mg
Product Synonyms
Mobic® tablets 7.5mg, Mobic® tablets 15mg, Mobec® tablets 7.5mg, Mobec® tablets 15mg, Mobex® tablets 7.5mg, Mobex® tablets 15mg, Mobicox® tablets 7.5mg, Mobicox® tablets 15mg, Movi-cox® tablets 7.5mg, Movi-cox® tablets 15mg, Aflamid® tablets 7.5 mg, Aflamid® tablets 15mg, Movalis® Tablets 7.5mg, Movalis® Tablets 15mg, Movatec® tablets 7.5mg, Movatec® tablets 15mg, Leutrol® Tablets 7.5 mg, Leutrol® Tablets 15mg with active ingredient: Meloxicam
1.2.1 Relevant identified uses
Pharmaceutical
1.2.2. Uses advised against
Safety Data Sheet only for the professional user
supplier name
Boehringer Ingelheim Pharmaceuticals Inc
Emergency telephone
+1 703-527-3887, +1 703-741-5970
Icons in SDS
Company Information
company name
Boehringer Ingelheim Pharmaceuticals Inc
e-mail address of the competent person responsible for the Safety Data Sheet
EHS-Services@Boehringer-Ingelheim.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H302, H360
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
Signal word
Danger
Hazard statements
H302 Harmful if swallowed. H360 May damage fertility or the unborn child.
Prevention
P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P264 Wash skin thoroughly after handling. P270 Do not eat, drink or smoke when using this product. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection.
Response
P301 + P312 + P330 IF SWALLOWED: Call a POISON CENTER/ doctor if you feel unwell. Rinse mouth. P308 + P313 IF exposed or concerned: Get medical advice/ attention.
Storage
P405 Store locked up.
Disposal
P501 Dispose of contents/ container to an approved waste dis- posal plant.
2.3 Other hazards
This drug is not subject to the labelling requirements under the Globally Harmonized System (GHS) The pharmacological effect of the medicament has to be considered (see package leaflet).
2.1 Classification of the substance or mixture
1910.1200) Acute toxicity (Oral) : Category 4 Reproductive toxicity
